Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available
On April 13, 2010, the Food and Drug Administration (FDA) announced that seven metered dose inhalers, including Maxair (pirbuterol), that contain chlorofluorocarbons (CFCs) are being phased out in the United States. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. The seven CFC inhalers are used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), or both. Alternative medications that do not contain CFCs are available. Dates for the phase-out of each CFC inhaler have been set. For Maxair Autohaler (pirbuterol), made by Graceway Pharmaceuticals, the last date for sale is Dec. 31, 2010. After this date, this CFC inhaler cannot be made, dispensed, or sold in the United States. For a complete list of the seven metered dose inhalers being phased out and more information about the phase out, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm207864.htm and http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm208138.htm
Learn More

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available
On April 13, 2010, the Food and Drug Administration (FDA) announced that seven metered dose inhalers, including Combivent (albuterol and ipratropium in combination), that contain chlorofluorocarbons (CFCs) are being phased out in the United States. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. The seven CFC inhalers are used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), or both. Alternative medications that do not contain CFCs are available. Dates for the phase-out of each CFC inhaler have been set. For Combivent Inhalation Aerosol (albuterol and ipratropium in combination), made by Boehringer Ingelheim Pharmaceuticals, the last date for sale is Dec. 31, 2013. After this date, this CFC inhaler cannot be made, dispensed, or sold in the United States. For a complete list of the seven metered dose inhalers being phased out and more information about the phase out, please visit: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm207864.htm and http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm208138.htm
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Maxair FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Albuterol Sulfate with Ipratropium Bromide FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Flunisolide Inhalation FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Cromolyn Sodium FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Triamcinolone Inhalation FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Metaproterenol FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Nedocromil FDA
2010-04-13 Voluntary Recall of Several Zyrtec Products Cetirizine Manufacturer
2010-04-13 Voluntary Recall of Several Infants' Motrin Products Ibuprofen Manufacturer
2010-04-13 Voluntary Recall of Several Children's Tylenol and Infants' Tylenol Products Acetaminophen Manufacturer
2010-04-13 Voluntary Recall of Certain Lots of Claritin Eye Drops Loratadine Manufacturer
2010-04-13 Oftalmi Announces Recall of the Camolyn Eye Drops Product Line Naphazoline FDA
2010-04-13 FDA Updates Healthcare Professionals on Suspension of Use of Rotarix Vaccine Rotavirus Vaccine FDA
2010-04-13 Recall of Select Lots of Selenium Sulfide Shampoo, 2.25% Selenium FDA
2010-04-13 Select Lots of Clearasil Ultra Recalled Because Lot Code Can Be Removed Benzoyl Peroxide FDA
2010-04-12 Aton Pharma, Inc. Recalls All Supplies of Demser capsules, 250 mg Metyrosine FDA
2010-04-12 Recall of Select Lots of Rosaderm Cleanser FDA
2010-04-12 Nycomed US, Inc. Recalls select lots of Fluocinonide Ointment USP, 0.05% Fluocinonide FDA
2010-04-12 Amoxicillin and Clavulanate Potassium for Oral Suspension: Recall by Ranbaxy Amoxicillin Sodium with Clavulanate Potassium FDA
2010-04-08 Recall of Our Family Ibuprofen Caplets 200 mg FDA